Dept. of the Army -- USAMRAA logo

DoW, Ovarian Cancer, Ovarian Cancer Academy – Early-Career Investigator Award

Dept. of the Army -- USAMRAA

Funding Amount

$4,500,000 total

Deadline

October 1, 2026

117 days left

Grant Type

federal

Overview

DoW, Ovarian Cancer, Ovarian Cancer Academy – Early-Career Investigator Award

Summary: Initially created in FY09, the OCRP Ovarian Cancer Academy (OCA) is a unique, interactive virtual academy providing intensive mentoring, national networking, collaborations, and a peer group for junior faculty. The overarching goal of the OCA is to conduct innovative and impactful ovarian cancer research while developing successful, highly productive ovarian cancer researchers in a collaborative research and career development environment. Distinctive Features: The OCA is a virtual career development and research training platform that consists of Early-Career Investigators (ECIs), their Designated Mentors, and an Academy Dean and Assistant Dean. The OCA-ECI Award is not a traditional career development award; the ECI is expected to participate in monthly webinars and annual workshops and to communicate and collaborate with other members of the Academy (other ECIs, Mentors, the Dean and Assistant Dean) as well as with the advocacy community.

Details

  • Agency: Dept. of the Army -- USAMRAA
  • Department: Department of Defense
  • Opportunity #: HT942526OCRPOCAECI
  • Total Funding: $4,500,000
  • Expected Awards: 4
  • Instrument: grant

Eligibility

Eligible Applicant Types

unrestricted

Focus Areas & Funding Uses

Fields of Work

science-research

Categories

Browse similar grants by category

Related Grants

Similar grants from this funder and related organizations

Ready to apply for DoW, Ovarian Cancer, Ovarian Cancer Academy – Early-Career Investigator Award?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.

You found DoW, Ovarian Cancer, Ovarian Cancer Academy – Early-Career Investigator Award. Now let's win it.

Start writing